Primary Care Internet Based Depression Prevention for Adolescents (CATCH-IT) Also Known as Promoting AdolescenT Health
Completed · Not applicable
Conditions studied: Major Depression, Depressive Episodes
In brief
The purpose of this randomized multiple-site clinical study is to determine whether a revised CATCH-IT (Internet-based depression prevention program) is more effective than a general health education Internet intervention (Health Education)on teens ages 13-18 (inclusive). It is hypothesized that teens in CATCH-IT will exhibit lower levels of depressed mood and/or maintain lower depressive scores over 2 years long-term follow up as compared to teens in Health Education group.
Key facts
- Study ID
- NCT01893749
- Run by
- Benjamin Van Voorhees, MD, MPH
- People needed
- 1142
- Starts
- 2012-02-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2019-08-22
Who can join
Age: 13 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adolescents:
- (A) Youth ages 13 through 18 who are English speaking. (B) Youth must be experiencing elevated level of depressive symptoms on the Center for Epidemiologic Studies Depression (CES-D) scale (score >/= 16). (C) Youth will be included if they have a past history of depression, anxiety, externalizing symptoms, or substance abuse. Youth presenting in partial remission from a major depressive episode at Baseline will be rescreened after 2 months utilizing the phone screen to ensure episode is fully remitted prior to randomization or access to study intervention. Those who do not fully remit after two months will be excluded.
- Parents:
- Parent of eligible adolescents
- Physicians (PCP) or NP:
- Physician in any of the study sites
- Healthcare Professionals:
- Primary care practice for a minimum of 6 months
You may not qualify if…
- Adolescents:
- Current DSM-IV diagnosis of Major Depressive Disorder
- Current therapy for depression, or be taking antidepressants (e.g., SSRIs, TCAs, MAOIs, bupropion, nefazodone, mirtazapine, venlafaxine);
- Current CES-D score >35;
- DSM-IV diagnosis of schizophrenia (current or past) or bipolar affective disorder;
- Current serious medical illness that causes significant disability or dysfunction;
- Significant reading impairment (a minimum sixth-grade reading level based on parental report), mental retardation, or developmental disabilities;
- Serious imminent suicidal risk (as determined by endorsement of current suicide on CES-D or in KSADS interview) or other conditions that may require immediate psychiatric hospitalization
- Psychotic features or disorders, or currently be receiving psychotropic medication
- Extreme, current drug/alcohol abuse (greater than or equal to 2 on the CRAFFT).
- Parents:
- Ineligible child
- Non-English speaking
- Physicians:
- None
- Healthcare Professionals:
- None
Where it is running
- ACCESS Healthcare Systems — Chicago, Illinois, United States
- University of Illinois — Chicago, Illinois, United States
- Northshore Healthcare Systems — Evanston, Illinois, United States
- Advocate Health Care — Oak Lawn, Illinois, United States
- Children's Clinic — Oak Park, Illinois, United States
- Franciscan St. Margaret Health — Dyer, Indiana, United States
- Wellesley Center for Women — Wellesley, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.